Jane Street
ARKG icon

Jane Street’s ARK Genomic Revolution ETF ARKG Stock Holding History

Jane Street’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.2M Sell
836,600
-81,300
-9% -$2.59M ﹤0.01% 1663
2026
Q1 		$24.3M Buy
917,900
+65,800
+8% +$1.93M ﹤0.01% 1616
2025
Q4 		$24.7M Buy
852,100
+423,900
+99% +$12.7M ﹤0.01% 1442
2025
Q3 		$11.9M Buy
428,200
+88,700
+26% +$2.24M ﹤0.01% 2196
2025
Q2 		$8.27M Buy
339,500
+277,300
+446% +$6.08M ﹤0.01% 2374
2025
Q1 		$1.29M Buy
62,200
+47,100
+312% +$1.18M ﹤0.01% 5095
2024
Q4 		$356K Sell
15,100
-68,800
-82% -$1.69M ﹤0.01% 7445
2024
Q3 		$2.15M Buy
83,900
+22,000
+36% +$560K ﹤0.01% 4333
2024
Q2 		$1.45M Sell
61,900
-38,000
-38% -$959K ﹤0.01% 5067
2024
Q1 		$2.87M Sell
99,900
-211,000
-68% -$6.35M ﹤0.01% 3476
2023
Q4 		$10.2M Buy
310,900
+188,800
+155% +$5.13M ﹤0.01% 1928
2023
Q3 		$3.4M Sell
122,100
-800
-0.7% -$26.2K ﹤0.01% 3179
2023
Q2 		$4.19M Buy
122,900
+28,600
+30% +$899K ﹤0.01% 2987
2023
Q1 		$2.84M Sell
94,300
-381,800
-80% -$11.8M ﹤0.01% 3239
2022
Q4 		$13.4M Sell
476,100
-390,000
-45% -$12.4M 0.01% 1331
2022
Q3 		$28.5M Buy
866,100
+270,200
+45% +$9.92M 0.01% 819
2022
Q2 		$18.8M Sell
595,900
-90,400
-13% -$3.16M 0.01% 1167
2022
Q1 		$31.5M Buy
686,300
+339,600
+98% +$16.2M 0.01% 945
2021
Q4 		$21.2M Sell
346,700
-153,400
-31% -$10.6M 0.01% 1166
2021
Q3 		$37.4M Sell
500,100
-215,900
-30% -$18.1M 0.01% 735
2021
Q2 		$66.2M Sell
716,000
-339,100
-32% -$28.8M 0.03% 435
2021
Q1 		$93.6M Buy
1,055,100
+1,015,300
+2,551% +$101M 0.05% 292
2020
Q4 		$3.71M Buy
+39,800
New +$3.17M ﹤0.01% 2513

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Jane Street's ARKG Position: Q2 2026 in Review

Jane Street reduced its ARK Genomic Revolution ETF (ARKG) stake by 54% in Q2 2026, selling an estimated $1.64M and leaving 44,710 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #5277.

Jane Street first reported a position in ARKG in Q4 2014 and has held it in 42 quarters since. The position peaked at $71.8M in Q4 2020. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Jane Street held 44,710 shares of ARK Genomic Revolution ETF worth $1.88M as of Q2 2026.
  • Jane Street sold 51,625 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $1.64M.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5277 holding.
  • Jane Street first reported a position in ARK Genomic Revolution ETF in Q4 2014 and has held it in 42 quarters since.
  • Jane Street's ARK Genomic Revolution ETF position peaked at $71.8M in Q4 2020.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.